Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Afatinib Dimaleate Tablets

Approval Number

国药准字HJ20170071

CompanyBoehringer Ingelheim International GmbH

Registration Date

July 12, 2021

Previous Approval Numbers

H20170071

Drug Information

Generic Name

马来酸阿法替尼片

Trade Name

吉泰瑞

Dosage Form

片剂

Strength

50mg(按C24H25ClFN5O3计)

Drug Type

化学药品

Registration Date

July 12, 2021

Expiry Date

July 11, 2026

Company Information

Applicant Company

Company NameBoehringer Ingelheim International GmbH

Company Address

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany

Manufacturing Company

Company NameBoehringer Ingelheim Pharma GmbH & Co. KG

Company Address

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

马来酸阿法替尼片 - NMPA 批准文号 | MedPath